EUA data worthy for sure. Secondary end points will confirm this to media. It’s up to manufacturing at this point. I was more worried about manufacturing than results to be honest. All that matters is the drug works. The flood gates are open for drug. It’s now worth A LOT of money!
The buyout depends on lymphocyte count in my opinion :)
Market Data 
Markets 
AI
